O-245 Randomized phase II clinical trial of cetuximab in combination with cisplatin and vinorelbine or cisplatin and vinorelbine alone in patients (pts) with advanced epidermal growth factor receptor (EGFR)-positive non-small-cell lung cancer (NSCLC)
Lung Cancer（2003）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要